Overview

Urokinase Therapy in Patients With Diabetic Foot Syndrome

Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the additional therapy with low dose urokinase is more effective than only a conventional standard therapy concerning ulcer-healing, rate of major amputation and survival.
Phase:
Phase 3
Details
Lead Sponsor:
medac GmbH